Insider Selling: Elisha Finney Sells 24,321 Shares of Varian Medical Systems Stock (VAR)
Varian Medical Systems (NYSE:VAR) CFO Elisha Finney sold 24,321 shares of the stock on the open market in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $77.69, for a total value of $1,889,498.49. Following the transaction, the chief financial officer now directly owns 4,308 shares in the company, valued at approximately $334,689. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.
VAR has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Varian Medical Systems in a research note to investors on Tuesday, December 10th. They now have a $83.00 price target on the stock. Finally, analysts at Jefferies Group raised their price target on shares of Varian Medical Systems from $78.00 to $80.00 in a research note to investors on Thursday, October 24th. They now have a “buy” rating on the stock. Two analysts have rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the stock. Varian Medical Systems currently has an average rating of “Hold” and an average price target of $74.90.
Shares of Varian Medical Systems (NYSE:VAR) traded up 0.18% on Friday, hitting $77.48. The stock had a trading volume of 633,948 shares. Varian Medical Systems has a 1-year low of $63.10 and a 1-year high of $80.66. The stock’s 50-day moving average is $76.86 and its 200-day moving average is $73.65. The company has a market cap of $8.191 billion and a P/E ratio of 19.43.
Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, October 23rd. The company reported $1.08 EPS for the quarter, missing the Thomson Reuters consensus estimate of $1.12 by $0.04. The company had revenue of $770.00 million for the quarter, compared to the consensus estimate of $779.02 million. During the same quarter in the prior year, the company posted $1.08 earnings per share. The company’s quarterly revenue was up 1.8% on a year-over-year basis.
Varian Medical Systems, Inc is engaged in the design, manufacture, sale and service of equipment and software products for treating cancer with radiotherapy, stereotactic radiotherapy, stereotactic body radiotherapy (NYSE:VAR), stereotactic radiosurgery (SRS) and brachytherapy.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.